PROSPERA: a randomized, controlled trial evaluating rasagiline in progressive supranuclear palsy
Crossref DOI link: https://doi.org/10.1007/s00415-016-8169-1
Published Online: 2016-05-26
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nuebling, Georg
Hensler, Mira
Paul, Sabine
Zwergal, Andreas
Crispin, Alexander
Lorenzl, Stefan
Funding for this research was provided by:
Teva Pharmaceutical Industries (IL)
Text and Data Mining valid from 2016-05-26